Praxis Precision Medicines, Inc. (PRAX)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

259.86 on 9 Oct 2026

1 buy2 sales at will1 planned sale

Fiscal year 2025, ended 31 Dec 2025, as filed

Revenue

$0.00

Net income

$303.27M

Free cash flow

$249.12M

Return on equity

-34.5%

Return on capital

-29.4%

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
24 Jun 2026	DeSimone Jill Director	Sold on a plan	$3.61M	83.2%
20 Nov 2025	Nemiroff Alex General Counsel and Secretary	Sold at will	$4.85M	54.7%
20 Nov 2025	Mastrocola Lauren Principal Accounting Officer	Sold at will	$2.61M	56.6%
16 Oct 2025	Adage Capital Management, L.P. 10% owner	Bought	$33.20M	15.3%
14 Nov 2024	Nemiroff Alex General Counsel and Secretary	Sold at will	$660.83K	44.4%
14 Nov 2024	Mastrocola Lauren Principal Accounting Officer	Sold at will	$424.32K	48.0%

35out of 100

Profitability 33

Financial strength 67

Growth 0

Insiders 43

Strongest on financial strength (67), weakest on growth (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$33.20M

1 buy, 1 buyer

Sold

$11.08M

3 sales

Planned sales

33%

under a 10b5-1 plan